Sinopep-Allsino Biopharmaceutical Co. Ltd. A Cash Flow-to-Debt Ratio
Sinopep-Allsino Biopharmaceutical Co. Ltd. A cash flow-to-debt ratio. Sinopep-Allsino Biopharmaceutical Co. Ltd. A (688076) has a Cash Flow-to-Debt Ratio of 0.02x as of September 2025, meaning its operating cash flow of CN¥68.66 Million could theoretically repay 0% of its total liabilities (CN¥3.56 Billion) in one year. Check earnings quality score of Sinopep-Allsino Biopharmaceutical Co. Lt to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Sinopep-Allsino Biopharmaceutical Co. Ltd. A (2013–2025)
Cash flow-to-debt ratio of Sinopep-Allsino Biopharmaceutical Co. Ltd. A from 2013 to 2025. Historical debt coverage capacity for Sinopep-Allsino Biopharmaceutical Co. Ltd. A across 13 annual periods. Check 688076 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Sinopep-Allsino Biopharmaceutical Co. Ltd. A Cash Flow-to-Debt Ratio by Year (2013–2025)
Sinopep-Allsino Biopharmaceutical Co. Ltd. A cash flow-to-debt ratio by year from 2013 to 2025. Year-by-year debt coverage analysis for Sinopep-Allsino Biopharmaceutical Co. Ltd. A. For the full cash flow conversion analysis, see cash efficiency ratio of Sinopep-Allsino Biopharmaceutical Co. Lt.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.18x | CN¥681.24 Million | CN¥3.74 Billion | ▲ +9.1% |
| 2024 | 0.17x | CN¥400.12 Million | CN¥2.40 Billion | ▼ -35.2% |
| 2023 | 0.26x | CN¥350.21 Million | CN¥1.36 Billion | ▲ +426.0% |
| 2022 | 0.05x | CN¥29.29 Million | CN¥597.41 Million | ▼ -91.4% |
| 2021 | 0.57x | CN¥180.75 Million | CN¥318.14 Million | ▲ +72.6% |
| 2020 | 0.33x | CN¥141.38 Million | CN¥429.55 Million | ▲ +189.3% |
| 2019 | 0.11x | CN¥46.14 Million | CN¥405.54 Million | ▼ -68.6% |
| 2018 | 0.36x | CN¥96.06 Million | CN¥265.47 Million | ▲ +845.4% |
| 2017 | 0.04x | CN¥11.11 Million | CN¥290.27 Million | ▲ +121.8% |
| 2016 | -0.18x | CN¥-21.95 Million | CN¥125.16 Million | ▲ +80.8% |
| 2015 | -0.91x | CN¥-112.62 Million | CN¥123.35 Million | ▼ -331.7% |
| 2014 | 0.39x | CN¥68.18 Million | CN¥173.05 Million | ▲ +47.2% |
| 2013 | 0.27x | CN¥43.67 Million | CN¥163.12 Million | — |